1. A kit comprising:an implantable pouch comprising a substrate defining a pocket, said pouch comprising a tyrosine-derived polyesteramide and a combination of minocycline and rifampin that is configured to elute over time; and
a hemostatic agent,
wherein the pouch is disposed in a first package and the hemostatic agent is disposed in a second package that is separate from the first package;
wherein the pocket is configured to receive a medical device.